Effects of Achieving SVR on Clinical Characteristics and Surgical Outcomes in Patients Who Developed Early-Stage HCV-Related Hepatocellular Carcinoma and Received Curative Resection: Preoperative versus Postoperative SVR
Authors:
- Po-Yao HsuPHPo-Yao Hsu
- Po-Cheng LiangPLPo-Cheng Liang
- Ching-I HuangCHChing-I Huang
- Meng-Hsuan HsiehMHMeng-Hsuan Hsieh
- Yi-Shan TsaiYTYi-Shan Tsai
- Tzu-Chun LinTLTzu-Chun Lin
- Ming-Lun YehMYMing-Lun Yeh
- Chung-Feng HuangCHChung-Feng Huang
- Chih-Wen WangCWChih-Wen Wang
- Tyng-Yuan JangTJTyng-Yuan Jang
- Yi-Hung LinYLYi-Hung Lin
- Zu-Yau LinZLZu-Yau Lin
Open Access
Abstract
The high accessibility to healthcare and increasing awareness of hepatocellular carcinoma (HCC) surveillance after sustained virologic response (SVR) to HCV treatment allow early detection of operable HCC in Taiwan. However, the effects of achieving SVR on patient characteristics and surgical outcomes after curative resection remain elusive. We aimed to compare the clinical presentation and postoperative prognosis among patients with early-stage HCV-related HCC and different viral status. We retrospectively analyzed 208 patients with BCLC stage 0 or A-HCC, including 44 patients who remained HCV viremic, 90 patients who developed HCC after achieving SVR (post-SVR HCC), and 74 patients who subsequently achieved SVR after resection. Patients with post-SVR HCC had a lower degree of hepatitis and better liver function than those who achieved SVR or remained viremic after resection. Notably, 75.6% of patients with post-SVR HCC did not have cirrhosis. Patients with post-SVR HCC and those achieving SVR after resection exhibited comparable recurrence rates and recurrence-free survival, while patients with persistent viremia had the worst surgical outcomes. We concluded that patients with post-SVR HCC had a better liver function but similar surgical outcomes compared with patients who achieved SVR after resection. The low prevalence of cirrhosis in patients with post-SVR HCC highlights the importance of regular surveillance after SVR.Keywords
Funding Information
- National Science Council of Taiwan (109-2314-B-037-045-MY3, 111-2314-B-037-102, NPUST kmU-111-P009)
- National Pingtung University of Science and Technology (109-2314-B-037-045-MY3, 111-2314-B-037-102, NPUST kmU-111-P009)
This publication has 42 references indexed in Scilit:
- Recurrence of Hepatocellular Cancer After ResectionAnnals of Surgery, 2015
- α-fetoprotein levels after interferon therapy and risk of hepatocarcinogenesis in chronic hepatitis CHepatology, 2013
- Impact of diabetes mellitus on incidence of hepatocellular carcinoma in chronic hepatitis C patients treated with interferon‐based antiviral therapyInternational Journal of Cancer, 2010
- Treatment of early hepatocellular carcinoma: How to predict and prevent recurrenceDigestive and Liver Disease, 2010
- Adjuvant interferon therapy after curative therapy for hepatocellular carcinoma (HCC): A meta-regression approachJournal of Hepatology, 2010
- Meta-analysis: interferon-alpha prevents the recurrence after curative treatment of hepatitis C virus-related hepatocellular carcinomaJournal of Viral Hepatitis, 2010
- Systematic review and meta-analysis of interferon after curative treatment of hepatocellular carcinoma in patients with viral hepatitisBritish Journal of Surgery, 2009
- Hepatocellular carcinoma in TaiwanHepatology Research, 2007
- Histological grading and staging of chronic hepatitisJournal of Hepatology, 1995
- Classification of chronic viral hepatitis: a need for reassessmentJournal of Hepatology, 1991